Keep your momentum
Learn how people with classical Hodgkin lymphoma who had a stem cell transplant responded in the AETHERA study.
About classical Hodgkin lymphoma after a stem cell transplant
Sometimes people receive a stem cell transplant if their disease is not well controlled after initial treatment. ADCETRIS may be given after a stem cell transplant to help reduce the risk of relapse or worsening disease. This is called consolidation treatment.
ADCETRIS is a well-established treatment backed by over a decade of clinical data
- Nearly 1700 patients with certain types of lymphoma received treatment with ADCETRIS across 8 clinical trials
- Over 67,000 patients in the US and over 183,000 patients worldwide have been treated with ADCETRIS since 2011
Healthcare providers have relied on the extensive clinical study data of ADCETRIS when treating their patients. Researchers continue to investigate ADCETRIS in clinical trials today.
Talk to your doctor about ADCETRIS
ADCETRIS patient brochure
This brochure is intended to help build knowledge and confidence through a detailed overview of ADCETRIS and can help inform treatment discussions with your doctor.
Doctor Discussion Guide
It's important to ask questions and share concerns about ADCETRIS treatment with a doctor. The Doctor Discussion Guide can help you navigate the conversation, so you get the most out of your visit. Take this printable PDF with you to your next appointment.
Glossary
Relapse: When cancer has returned after signs and symptoms of cancer had reduced or became undetectable.
Stem cell transplant: A procedure in which a patient receives healthy stem cells (blood-forming cells) to replace their own stem cells that have been destroyed by certain cancer treatments.